| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 51,774 | 55,599 | 42,147 | 60,247 | | Cost of Revenue | 42,923 | 50,381 | 47,002 | 53,000 | | | Gross Profit | 8,851 | 5,218 | (4,855) | 7,247 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,498 | 3,789 | (2,373) | 9,638 | | Non Recurring |
-
|
-
| (313) |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,353 | 1,429 | (2,169) | (2,391) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (10) | 10 | 7 | (314) | | Earnings Before Interest And Taxes | 3,365 | 1,439 | (2,162) | (2,705) | | Interest Expense |
-
|
-
| 257 |
-
| | Income Before Tax | 3,365 | 1,439 | (2,419) | (2,705) | | Income Tax Expense | 144 | 278 | (700) | (616) | | Minority Interest |
-
|
-
| (133) |
-
| | | | Net Income From Continuing Ops | 3,221 | 1,161 | (1,852) | (2,089) | | | Non-recurring Events | | Discontinued Operations |
-
| (55) | (634) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,221 | 1,106 | (2,486) | (2,089) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,221 | $1,106 | ($2,486) | ($2,089) |
|
0.01% Nasdaq 
0.01 (0.39%) 
Income Statement
